You raise an interesting point Mr P. The finanical stuff is...

You raise an interesting point Mr P. The finanical stuff is indeed up to 31/12. That said there is scope for post 31/12 financial impact up into the date of signing - presumably on or the day before date of release. Our financial stuff is very straightforward. No revenue & cash outflows. The more intersting info will be contained in the business update - which is not financially impactful but informative. That should be current up to date of Ann release. Key & only driver will obviously be patient recruitment. Silence on that will not be good. Blah blah around tox results & other potential treatments & partnering opportunities will be dismissed by the market and simply seen as kicking the can down the road. Fingers X for some meaningful recruitment narrative.